Mounjaro®
Starting from £179.99/mo
Start journey Learn moreTo get Mounjaro in the UK, you need a prescription from a registered prescriber following a clinical assessment — it cannot be purchased over the counter or without one. Adults with a BMI of 30 or above, or 27 or above with a weight-related health condition, may qualify. The right route depends on several things: your health profile, your BMI, whether you meet NHS criteria, and how quickly you need to start. This page walks through each factor so you can make a clear-eyed decision — and if a private consultation is the path that fits, you can begin one at no cost.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The licensed eligibility criteria for Mounjaro are the starting point, not a guarantee. The medicine is approved in the UK for adults with a BMI of 30 or above, or a BMI between 27 and 29.9 if there is at least one weight-related comorbidity, prediabetes, established type 2 diabetes, hypertension, obstructive sleep apnoea, or high cholesterol are among the qualifying conditions. If you want a quick self-check before anything else, the NHS BMI calculator takes less than a minute and gives you a starting number.
BMI alone never settles the question. A prescriber will look at your full medical history, any medicines you already take, and whether any conditions make Mounjaro unsuitable. People with a personal or family history of certain thyroid cancers, for instance, or who are pregnant, breastfeeding, or actively trying to conceive, would not be prescribed it. The assessment exists precisely to catch these things. For a fuller picture of who the medicine is and isn't suited for, the conditions that rule Mounjaro out are worth reading before you apply anywhere.
One more thing: UK guidance applies slightly lower BMI thresholds for some ethnic backgrounds (the adjustment is 2.5 kg/m²) so if your BMI sits just below 30, that may still be worth discussing with a prescriber. You can read more about BMI requirements for Mounjaro in detail, including how those thresholds are applied in practice.
The NHS does prescribe Mounjaro, but access is phased and the criteria are tight. NHS England's current rollout (as of summer 2026) covers adults with a BMI of 40 or above alongside four or more of five specified conditions: high blood pressure, dyslipidaemia, obstructive sleep apnoea, cardiovascular disease, and type 2 diabetes. A second cohort (BMI 35 to 39.9 with four or more of the same conditions) became eligible in June 2026. Even if you meet those criteria, your GP's practice must be participating in the new prescribing arrangement, and you'll need to engage with wrap-around dietary and activity support. Waiting times vary considerably by area.
If you don't meet those NHS thresholds, or you'd rather not wait, a private regulated pharmacy is the legal alternative. The clinical standard doesn't change, you still need a genuine assessment by a qualified prescriber. What changes is the speed and the eligibility bar, which follows the broader licensed criteria rather than the narrower NHS phased rollout. NICE's appraisal of tirzepatide sets out the full evidence base and NHS recommendations if you want to read the original guidance.
Whichever route you're considering, the process of getting Mounjaro specifically for weight loss involves the same clinical questions, your route determines the speed and waiting time, not the safety standard.
This is where a lot of people come unstuck. Mounjaro's profile has attracted sellers who offer it without any real clinical assessment, sometimes with counterfeit pens. The MHRA has made multiple public warnings about fake weight-loss pens sold via social media and unofficial websites, and fake pens have caused real harm, in some cases containing insulin. Any seller offering tirzepatide without a genuine prescriber assessment is operating outside the law.
The check is simple: every legitimate online pharmacy in the UK must be registered with the General Pharmaceutical Council. You can verify any pharmacy, including nume's GPhC registration (9012878), in seconds on the GPhC register. If a seller isn't listed there, walk away. Prices far below the market rate, discount codes, and promises of instant approval with no questions are all warning signs rather than bargains.
At nume, every consultation is read by a GPhC-registered Independent Prescriber, a real clinician, not automated software. If you order before midday on a working day and your prescription is approved, your treatment is dispatched the same day and arrives via tracked DPD the next working day in plain, unbranded packaging. The cost of private treatment varies by dose and provider; you can see a realistic picture of what private treatment involves on our Mounjaro cost page.
Getting Mounjaro is the beginning of a clinical process, not a one-time transaction. Treatment starts at 2.5mg (a tolerability dose designed to let your system adjust) and is titrated upward by the prescriber over subsequent months. Every repeat order at nume is re-reviewed before dispatch; no automatic renewals, no prescription running indefinitely in the background.
NICE guidance notes that if less than 5% weight loss has occurred after six months at the highest tolerated dose, continuing the medicine should be reviewed. That's not a failure point, it's a built-in clinical checkpoint, and it's one reason ongoing prescriber oversight matters. Questions about timing, missed doses, or how flexible the weekly schedule can be are best answered by your prescriber, though our page on how late you can take a dose covers the practical detail.
If you've read through the above and want to find out whether you're eligible, you can check who can get Mounjaro before taking the next step, which is a clinical conversation, not a purchase. Start your free consultation and a prescriber will review your details the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.